Asiatic Laboratories Cash Flow Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	FY 2022	FY 2021	FY 2020
Period Ending	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Net Income	-	320.52	242.45
Depreciation & Amortization	-	104.9	94.28
Other Amortization	-	0.5	0.21
Other Operating Activities	-	44.2	93.5
Change in Accounts Receivable	-	-15.91	-21.63
Change in Inventory	-	-32.58	-45.81
Change in Accounts Payable	-	-4.86	-10.58
Change in Other Net Operating Assets	-	15.23	-7.82
Operating Cash Flow	-	432.01	344.61
Operating Cash Flow Growth	-	25.36%	-
Capital Expenditures	-	-375.1	-185.33
Sale (Purchase) of Intangibles	-	-	-3.5
Investing Cash Flow	-	-375.1	-188.83
Short-Term Debt Repaid	-	-0.31	-63.51
Long-Term Debt Repaid	-	-14.83	-38.22
Total Debt Repaid	-	-15.14	-101.73
Net Debt Issued (Repaid)	-	-15.14	-101.73
Other Financing Activities	-	-44.32	-51.74
Financing Cash Flow	-	-59.47	-153.47
Foreign Exchange Rate Adjustments	-	0.27	0.17
Net Cash Flow	-	-2.28	2.48
Free Cash Flow	-	56.91	159.27
Free Cash Flow Growth	-	-64.27%	-
Free Cash Flow Margin	-	3.92%	12.01%
Free Cash Flow Per Share	-	0.65	1.81
Cash Interest Paid	-	43.92	51.38
Cash Income Tax Paid	-	44.1	54.85
Levered Free Cash Flow	-	-55.04	-
Unlevered Free Cash Flow	-	-27.59	-
Change in Working Capital	-	-38.12	-85.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.